Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases;Utilisation du bevacizumab en injection intravitréenne dans le traitement du glaucome néovasculaire. propos de 20 cas

Journal Francais d'Ophtalmologie

Volumn 32, Issue 9, 2009, Pages 652-663

  Douat, J ^a   Auriol, S ^a   Mahieu Durringer, L ^a   Ancle, E ^a   Pagot Mathis, V ^a   Mathis, A ^a  

^a CHU RANGUEIL   (France)

Author keywords

Antiangiogenic agent; Bevacizumab; Carotid stenose; Diabetic retinopathy; Intravitreal injection; Neovascular glaucoma; Retinal vein occlusion; VEGF

Indexed keywords

BEVACIZUMAB; MONOCLONAL ANTIBODY;

AGED; ARTICLE; CLINICAL TRIAL; DIABETIC RETINOPATHY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INJECTION; LASER COAGULATION; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEOVASCULAR GLAUCOMA; OCULOPLETHYSMOGRAPHY; RETINA ARTERY OCCLUSION; RETINA VEIN OCCLUSION; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS BODY;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, NEOVASCULAR; HUMANS; INJECTIONS; LASER COAGULATION; MALE; MIDDLE AGED; RETINAL ARTERY OCCLUSION; RETINAL VEIN OCCLUSION; SEVERITY OF ILLNESS INDEX; TONOMETRY, OCULAR; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS BODY;

EID: 73449132535     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfo.2009.10.001     Document Type: Article

References (28)

1. Hayreh SS. Neovascular glaucoma. Prog Retin Eye Res 2007;26:470-485
2. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, et al.. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-2342
3. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004;25:581-611. (Pubitemid 39099316)
4. Hamard P, Baudoin C. Consensus sur le glaucome néovasculaire. J Fr Ophtalmol 2000;23:289-294
5. Korobelnik JF, Cochereau I, Cohen SY, Coscas G, Creuzot- Garcher C, Devin F, et al.. Description des pratiques pour la réalisation des injections intravitréennes. J Fr Ophtalmol 2006;29:82-86
6. Fung AE, Rosenfeld PJ, Reichel E. The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 2006;90:1344-1349
7. Gordon MS, Cunningham D. Managing patients treated with bevacizumab combination therapy. Oncology 2005;69(Suppl 3):25-33.
8. Giantonio BJ, Levy DE, O'dwyer PJ, Meropol NJ, Catalano PJ, Benson AB, 3rd, et al.. A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the Eastern Cooperative Oncology Group study E2200. Ann Oncol 2006;17:1399-1403
9. The diabetic retinopathy study research g. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 1976; 81:383-396
10. The Central Vein Occlusion Study G. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 1997; 115:486-491
11. The Central Vein Occlusion Study G N report. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. Ophthalmology 1995; 102:1434-1444
12. Hayreh SS, Klugman MR, Podhajsky P, Servais GE, Perkins ES. Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion--a 10-year prospective study. Graefes Arch Clin Exp Ophthalmol 1990;228:281-296
13. Adamis AP, Altaweel M, Bressler NM, Cunningham Jr ET, Davis MD, Goldbaum M, et al.. Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals. Ophthalmology 2006;113:23-28
14. Oshima Y, Sakaguchi H, Gomi F, Tano Y. Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. Am J Ophthalmol 2006;142:155-158
15. Grisanti S, Biester S, Peters S, Tatar O, Ziemssen F, Bartz- Schmidt KU, et al.. Intracameral bevacizumab for iris rubeosis. Am J Ophthalmol 2006;142:158-160
16. Davidorf FH, Mouser JG, Derick RJ. Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina 2006;26:354-356
17. Spaide RF, Fisher YL. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 2006;26:275-278
18. Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, et al.. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006;113, 1695.e1-15
19. Buys YM. Bevacizumab: the need for controlled studies to move forward. Can J Ophthalmol 2007;42:789.
20. Diabetic Retinopathy Clinical Research Network, Scott IU, Edwards AR, Beck RW, Bressler NM, Chan CK, et al.. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology 2007; 114:1860-1867
21. Amselem L, Montero J, Diaz-Llopis M, Pulido JS, Bakri SJ, Palomares P, et al.. Intravitreal bevacizumab (Avastin) injection in ocular ischemic syndrome. Am J Ophthalmol 2007;144:122-124
22. Iliev ME, Domig D, Wolf-Schnurrbursch U, Wolf S, Sarra GM. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol 2006;142:1054-1056
23. Tripathi RC, Li J, Tripathi BJ, Chalam KV, Adamis AP. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology 1998;105:232-237
24. Every SG, Molteno AC, Bevin TH, Herbison P. Long-term results of Molteno implant insertion in cases of neovascular glaucoma. Arch Ophthalmol 2006;124:355-360
25. Elgin U, Berker N, Batman A, Simsek T, Cankaya B. Trabeculectomy with mitomycin C combined with direct cauterization of peripheral iris in the management of neovascular glaucoma. J Glaucoma 2006;15:466-470
26. Jonas JB, Spandau UH, Schlichtenbrede F. Intravitreal bevacizumab for filtering surgery. Ophthalmic Res 2007;39: 121-122
27. Schlote T, Kreutzer B, Kriegerowski M, Knorr M, Thiel HJ. Diode laser cyclophotocoagulation in treatment of therapy refractory glaucoma. Klin Monatsbl Augenheilkd 1997;211:250-256
28. Arevalo JF, Maia M, Flynn Jr HW, Saravia M, Avery RL, Wu L, et al.. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol 2008;92:213-216